EXTENDED PDF FORMAT SPONSORED BY Lummex® Multiplex Immunoassays One simple solution for profiling your complex samples KD systems* >LearnMore www.rndsystems.com Voltage-Gated Sodium Channel in Grasshopper Mice Defends Against Bark Scorpion Toxin Ashlee H. Rowe et al. Science 342, 441 (2013); DOI: 10.1126/science. 1236451 This copy is for your personal, non-commercial use only. If you wish to distribute this article to others, you can order high-quality copies for your colleagues, clients, or customers by clicking here. Permission to republish or repurpose articles or portions of articles can be obtained by following the guidelines here. The following resources related to this article are available online at www.sciencemag.org (this information is current as of October 25, 2013 ): o 1% induce a biphasic response in rodents; an immediate, brief response mediated, in part, by the nociceptor-expressed transient receptor potential Fig. 4. Domain II is the major contributor to the sensitivity of O. torridus Navl.8 to C. sculpturatus venom. (A) Schematic diagram of sodium channel a subunit Navl.8 from 0. torridus (otNavl.8) and M. musculus (mNavl.8). 0, to 0|V and M, to M,v represent four different domains of otNavl.8 and mNavl.8, respectively. (B) C. sculpturatus venom in-hibited otNavl.8 TTX-resistant Na+ current, but not mNavl.8, expressed by ND7/23 cells. Cells were pretreated with 500 nWI TTX to block TTX-sensitive (i.e., Navl.7) currents and held at -80 mV. Na+ currents were induced by 50-ms depolarizing steps to various potentials ranging from -80 to +60 mV in 5-mV increments. All currents elicited before (controD and after venom treatment were normalized to the maximum amplitude of control peak current. (C) Concentration-response inhibitory curves for C. sculpturatus venom on wild-type otNavl.8 (0|0M0|||0|v, filled circles) and mNavl.8 (M|MMM|||M|v, open circles). The IC50 for otNavl.8 was 2.2 ug/ml. (D) Effects of C. sculpturatus venom on four otNavl.8/mNavl.8 chimeras. Each of the four domains in otNavl.8 was replaced by the corresponding domain from mNavl.8. Venom inhibited Na+ current expressed by chimeras where domains I, III, and IV were Extracellular Intracellular CO2" Extracellular Intracellular CO2" -e- venom control 10 u,g/ml venom • control -e- venom 20 ms ■40 0 40 membrane potential (mV) ■e- MiMiiMhiMiv f^J -.-OAAAv J MAAA\, + OMPnAv ^ OAMmOw OAA|Mw -•- M|M||M|||M|v -A- MPuMniMiv -5 -4 -3 -2 -1 log[venom], mg/ml exchanged (IC50 values: M|0M0|||0|v = 1.5 |xg/ml; 0|0MM|||0|v = 3.0 ug/ml; 0|0||0|||M|V = 2.4 ug/ml). Venom had no effect on the domain II chimera (IC50 value: 0|M||0M|0|v > 524.6 ug/ml). (E) The reverse replacement of otNavl.8-Dll significantly increased the sensitivity of mNavl.8 to C. sculpturatus venom (IC50 value: M|0MM|||M|v = 3.2 ug/ml). Each data point is shown as the mean ± SE. Data for (C) to (E) were obtained from 3 to 7 separate cells expressing each channel construct. www.sciencemag.org SCIENCE VOL 342 25 OCTOBER 2013 443 RESEARCH ARTICLES cation channel (TRPA1), and a delayed, persistent response mediated by inflammatory agents and changes to the CNS (11,12, 25, 26). To minimize responses due to tissue inflammation, we measured paw licking during the 5-min period immediately after formalin injections. A two-way analysis of variance (ANOVA) revealed a significant species-by-treatment interaction. M. musculus licked their paws more in response to formalin after pretreatment with venom as compared to formalin without venom pretreatment (fig. S4). However, O. torridus decreased their paw licking in response to formalin when pretreated with venom (fig. S4). We replicated this study using lower concentrations of formalin (<1%) to elicit nociceptor-mediated paw licking and further minimize inflammation-induced licking. We accomplished this by selecting doses of formalin that produced paw licking within the first 10 min after formalin injections, but that produced little or no licking after 10 min (fig. S5). The results of the replicated study confirmed that pretreating with venom before formalin injections significantly increased paw licking in M. musculus but significantly decreased paw licking in O. torridus (Fig. 3C). Navl.8 Molecular Structure Voltage-gated Na+ channels are membrane-spanning proteins constructed of four homologous domains (DI to DIV), with six transmembrane segments (SI to S6) composing each domain [27-29) (fig. S6A). Positively charged residues in S4 of each domain serve as sensors that detect changes in membrane voltage to regulate channel gating. The reentrant loop between S5 and S6 in each domain join to form the channel pore. Venoms of buthid scorpions such as C. sculpturatus consist of multiple, low-molecular weight peptides that bind either to the amino acids in the extracellular loops connecting the transmembrane segments or to the residues lining the pore of the channel (10, 30-34). Because C. sculpturatus venom inhibits TTX-R Na+ current in O. torridus Navl.8 but has no effect on M. musculus, we predicted that the structure of Navl.8 would differ between the two species. To identify structural differences, we cloned and sequenced the gene (ScnlOa) that encodes Navl.8 from O. torridus and compared it to orthologous sequence from M. musculus. We identified multiple amino acid variants in O. torridus Navl.8 (fig. S6, A and B). Many of these variants were distributed throughout the extracellular loops and pore region of the channel where they would be accessible to venom peptides. Navl.8 Chimeras To identify the region of the channel critical for venom-induced inhibition of Na+ current, we made constructs of Navl.8 for O. torridus (otNavl.8) and M. musculus (mNavl .8) by inserting ScnlOa from each species into expression vectors (Fig. 4A). We confirmed that C. sculpturatus venom had no effect on mNavl.8 Na+ current but dose depen- dently blocked otNavl.8 (Fig. 4, B and C). Using otNavl .8 as the framework, we made four chimeras in which each domain of otNavl .8 was replaced with the corresponding domain from mNavl .8. We tested venom on the chimeras and found that replacing domain I in otNavl .8 did not affect venom activity, and replacing domains HI and IVonly slightly reduced venom activity (Fig. 4D). However, replacing domain II in otNavl.8 with the corresponding domain from mNavl.8 abolished the effects of the venom on the channel (Fig. 4D). Moreover, reversing the chimera by using mNavl .8 as the framework and replacing domain II with the corresponding domain from otNavl .8, imparted venom sensitivity to mNavl .8 (Fig. 4E). C. sculpturatus venom dose dependent-ly inhibited mNavl .8 Na+ current after exchanging domain II with otNavl .8. Thus, domain II is the major contributor to venom sensitivity in otNavl.8. Site-Directed Mutagenesis To identify the amino acid(s) in domain II that impart venom sensitivity to otNavl .8, we used site-directed mutagenesis to replace amino acid variants in otNavl.8 domain II with residues corresponding to the same positions in mNavl.8. Initially we focused on two amino acid variants expressed in O. torridus domain IIS3-S4 because scorpion peptides known to target domain II in other Na+ channels bind to amino acids in this loop (31). We replaced two hydrophobic amino acids (I746 and otNavl. mNavl. LLELSIAKKGSLSVLR LLELSTSKKGSLSVLR -S3 II-S4 ■ control 3 2=B -S5 Fig. 5. An acidic residue (E862) in domain II near the pore region (SS2-S6 linker) plays a critical role in the sensitivity of otNavl.8 to C. sculpturatus venom. (A) The amino acid sequence representing domain IIS3-S4 and S5-S6 linkers from otNavl.8 is aligned with the corresponding sequence from mNavl.8. The position of each amino acid residue of interest is designated with a number. (B) Effects of C. sculpturatus venom on wild-type and mutant Navl.8 channels expressed by ND7/23 cells. Cells were pretreated with 500 nM TTX and held at-80 mV. Representative current traces before (control, black) and after 10 ug/ml venom treatment (orange) were elicited by a 50-ms depolarizing potential of +20 mV. (C) Concentration-response inhibitory curves show the effect of C. sculpturatus venom on wild-type and mutant otNavl.8 channels. C. sculpturatus venom IC50 values were estimated to be >251.4 ug/ml on the single-mutant E862Q and >531.5 )rg/ml on the double-mutant Q859E/E862Q, respectively. (D) The reverse mutation Q861E in mNavl.8 increased the sensitivity of the channel to C. sculpturatus LLGEDYGCRKDGTALWNEGQLRWHMCDFFHSFLVIFRILCGEWIENMWVCMQVSEKSICLI LLSENYGCRRDGISVWNGERLRWHMCDFFHSFLWFRILCGEWIENMWVCMEVSQDYICLT SS1 SS2 - CM lo co oo oo FFHSFLVIFRILCGEWIENMWVCM VS KSICLILFLTVMVLGNLWLNLFIALLLNSFSA FFHSFLVIFRILCGEWIENMWVCMEVG KSICLILFLTVMVLGNLWLNLFIALLLNSFSA FFHSFLVIFRILCGEWIENMWVCMQVSEKYICLILFLTVMVLGNLWLNLFIALLLNSFSA FFHSFLWFRILCGEWIENMWVCMEVSQDYICLTLFLTVMVLGNLWLNLFIALLLNSFSA FFHSFLWFRILCGEWIENMWVCMEVSQKSICLILFLTVMVLGNLWLNLFIALLLNSFSA FFHSFLIVFRILCGEWIENMWACMEVSEKSICLVLFLTVMVLGNLWLNLFIALLLNSFSA FFHSFLIVFRILCGEWIENMWACMEVSQKSICLILFLTVMVLGNLWLNLFIALLLNSFSA FFHSFLIIFRILCGEWIENMWACMEVSEKPICLILFLTVMVLGNLWLNLFIALLLNSFSA FFHSFLIVFRILCGEWIENMWACMQVS KPLCLILFLTVMVLGNLWLNLFIALLLNSFSA FYHSFLIVFRILCGEWIENMWACMEVSEKPVCLILFLTVMVLGNLWLNLFIALLLNSFSA FFHSFLIVFRILCGEWIENMWACMEVSEKSICLILFLTVMVLGNLWLNLFIALLLSSFSA FFHSFLIIFRILCGEWIENMWACMQVGEKSICLVLFLTVMVLGNLWLNLFIALLLNSFSA FFHSFLIVFRILCGEWIENMWACHEVGQKSICLILFLTVMVLGNLWLNLFIALLLNSFSA FFHSFLIVFRILCGEWIENMWACMEVGQKSICLILFLTVMVLGNLWLNLFIALLLNSFSA FFHSFLVIFRILCGEWIENMWVCMQVGQKSICLILFLTVMVLGNLWLNLFIALLLNSFSA FFHSFLIVFRILCGEWIENMWSCMQVGQQSICLVLFLMVMVLGNLWLNLFIALLLNSFSA FFHSFLIVFRILCGEWIENMWACMEVGQKSICLILFLTVMVLGNLWLNLFIALLLNSFSA FFHSFLIVFRILCGEWIENMWACMEVGQKSICLILFLTVMVLGNLWLNLFIALLLNSFSA FFHSFLIVFRILCGEWIENMWACLEVGQKSICLILFLMVMVLGNLWLNLFIALLLNSFSA *.****. ************* *. »** *** ********************** Cavia porcellus (guinea pig, XM_003464141); Chinchillidae: Chinchilla lanigera (long-tailed chinchilla, XM_005386574); Octodontidae: Octodon degus (degu, XM_004642215)]. Nonrodent mammals [Galagidae: Otolemur garnettii (small-eared galago, XM_003794468); Cercopithecidae: Papio anubis (olive baboon, XM_003894661); Hominidae: Homo sapiens (human, NM_006514); Talpidae: Condylura cristata (star-nosed mole, XM_004676631); Soricidae: Sorex araneus (European shrew, XM_004614563); Felidae: Felis catus (domestic cat, XM 003992249); Bovidae: Bos taurus (cattle, XM 002696916); Elephantidae: Loxodonta africana (African elephant, XM_003415747)]. www.sciencemag.org SCIENCE VOL 342 25 OCTOBER 2013 445 RESEARCH ARTICLES that were not associated with scorpion venom. O. torridus can use this negatively charged amino acid to reduce their sensitivity to venom-induced pain. Discussion Pain sensitivity is critical for survival. Thus, many animals use painful venom to deter predators. Because voltage-gated Na+ channels play a major role in transmitting sensory-pain signals to the CNS, they are often the targets of pain-inducing venoms. C. sculpturatus venom induces pain by activating the channel (Navl.7) responsible for initiating pain signaling in nociceptors. Although pain-inducing venom could impose strong selection on the receiver, counteradaptation may be constrained by the risks associated with reduced pain sensitivity. Given the important role of Na+ channels in pain signaling, counteradaptation may also be constrained by the conservation of Na+ channel structure and function. However, O. torridus can sustain multiple stings during predatory attacks on C. sculpturatus. In O. torridus. the channel (Navl .8) responsible for transmitting pain signals to their CNS has amino acid variants that bind venom peptides and inhibit channel current, blocking pain signals instead of transmitting them. This mechanism represents a unique evolutionary strategy as many examples of resistance to deadly toxins involve structural modifications to the target channel or receptor that interfere with toxin binding [e.g., resistance to cobra toxin (35, 36), resistance to tetrodotoxin (37—40)]. In O. torridus, however, a channel (Navl .8) that is not the target of the venom has amino acid variants that facilitate venom binding. Moreover, scorpion peptides that target Na+ channels typically activate the channel or block inacti-vation, prolonging channel activity and increasing neuron excitability (31, 32). In contrast, scorpion peptides inhibit O. torridus Navl .8 Na+ current and decrease neuron excitability, blocking neuronal signaling and inducing analgesia. A fascinating parallel to the grasshopper mouse-bark scorpion case involves African naked mole rats that are insensitive to acid-induced pain (41, 42). Naked mole rats live in subterranean colonies where they are exposed to high concentrations of carbon dioxide (C02). Increased C02 environments induce pain by activating proton-gated acid sensors expressed in nociceptors. Instead of modifications to the proton-gated acid sensors, naked mole rats evolved amino acid variants in Navl .7, the channel responsible for initiating pain signals in nociceptors. In naked mole rats, protons bind to the pore region of Navl.7 and block Na+ current, inhibiting action potential initiation and preventing pain signaling. Thus, in naked mole rats, a nontarget Na+ channel expressed in the sensory pain pathway evolved structural variations that facilitate proton binding, ultimately blocking the pain signals that the protons are initiating. The pain-reducing mechanisms observed in southern grasshopper mice and African naked mole rats are exciting because they demonstrate that although Na+ channels are structurally conserved, variation exists among species. Moreover, slight variations in Na+ channel structure can produce substantial physiological effects. Reversing the positions of a hydrophilic and an acidic amino acid in Navl.8 is critical for imparting venom-pain insensitivity to O. torridus, and converting a positively charged amino acid motif to a negatively charged motif in Nav 1.7 renders naked mole rats insensitive to acid-induced pain. Because the amino acid variants in O. torridus Navl .8 and naked mole rat Navl.7 are each directed against the source of the pain (venom peptides and protons, respectively), O. torridus can exploit a biochemically protected food resource and naked mole rats can live in subterranean colonies while circumventing the constraints associated with evolving generally desensitized nociceptors. Future studies should examine whether there has been counterselection on C. sculpturatus, perhaps resulting in peptides modified to overcome the mice's resistance to this scorpion's painful sting. Given that venom toxins and their ion-channel targets are both products of gene families, C. sculpturatus and O. torridus provide an excellent model for investigating coevolution and arms races at the molecular and biochemical levels. C. sculpturatus and O. torridus also provide a unique model for analgesia studies. Navl.7 is considered a target for analgesic development because of its role in human pain disorders (13). However, our results demonstrate the key role Navl .8 plays in pain signaling and its potential to serve as an analgesic target. Moreover, given that few toxins have been identified that bind Navl .8, and none that bind selectively (43), the molecular and biochemical interactions between venom peptides and Navl.8 could serve as the basis for designing highly selective, nonaddictive analgesics. References and Notes 1. ]. ]. Cox et ai, Nature 444, 894-898 (2006). 2. ]. 0. Schmidt, in Insect Defenses: Adaptive Mechanisms and Strategies of Prey and Predators, D. L. Evans, Ed. (State University of New York Press, Albany, NY, 1990), pp. 383-417. 3. S. C. Curry, M. V. Vance, P. ]. Ryan, D. B. Kunkel, W. T. Northey,Toxicol. Clin. Toxicol. 21, 417-449 (1983). 4. V. Fet, G. Lowe, in Catalog of the Scorpions of the World (1758-1998), V. Fet, W. D. Sissom, G. Lowe, M. E. Braunwalder, Eds. (New York Entomological Society, New York, 2000), vol. 1, pp. 54-286. 5. F. LoVecchio, C. McBride, ]. Toxicol. Clin. Toxicol. 41, 937-940 (2003). 6. L. V. Boyer et ai, N. Engl. J. Med. 360, 2090-2098 (2009). 7. A. B. Skolnik, M. B. Ewald, Pediatr. Emerg. Care 29, 98-103, quiz 104-105 (2013). 8. A. H. Rowe, M. P. Rowe, Toxicon 52, 597-605 (2008). 9. A. H. Rowe, M. P. Rowe, Anim. Behav. 71, 725-734 (2006). 10. ]. M. Simard, H. Meves, D. D. Watt, in Natural Toxins: Toxicolgy, Chemistry and Safety, R. F. Keeler, N. B. Mandava, A. T. Tu, Eds. (Alaken, Fort Collins, CO, 1992), vol. 1, pp. 236-263. 11. A. Tjalsen, 0. G. Berge, S. Hunskaar, ]. H. Rosland, K. Hole, Pain 51, 5-17 (1992). 12. K. ]. Sufka, G. S. Watson, R. E. Nothdurft, ]. S. Mogil, Eur. J. Pain 2, 351-358 (1998). 13. S. D. Dib-Hajj, T. R. Cummins, ]. A. Black, S. G. Waxman, Annu. Rev. Neurosci. 33, 325-347 (2010). 14. T. R. Cummins et ai, ]. Neurosci. 19, RC43 (1999). 15. S. Dib-Hajj, ]. A. Black, T. R. Cummins, S. G. Waxman, Trends Neurosci. 25, 253-259 (2002). 16. S. Lolignier et ai, PLOS ONE 6, e23083 (2011). 17. S. Leo, R. D'Hooge, T. Meert, Behav. Brain Res. 208, 149-157 (2010). 18. C. Y. Saab, T. R. Cummins, S. D. Dib-Hajj, S. G. Waxman, Neurosci. Lett. 331, 79-82 (2002). 19. C. Maertens et ai, Mol. Pharmacol. 70, 405-414 (2006). 20. E. R. Moraes, E. Kalapothakis, L. A. Naves, C. Kushmerick, Neurotox. Res. 19, 102-114 (2011). 21. A. H. Rowe et ai, PLoS ONE 6, e23520 (2011). 22. M. Renganathan, T. R. Cummins, S. G. Waxman, }. Neurophysiol. 86, 629-640 (2001). 23. N. T. Blair, B. P. BeanJ. Neurosci. 22,10277-10290 (2002). 24. J.-S. Choi, S. G. Waxman, J. Neurophysiol. 106, 3173-3184 (2011). 25. C. R. McNamara et ai, Proc. Natl. Acad. Sci. U.S.A. 104, 13525-13530 (2007). 26. S. D. Shields, D. ]. Cavanaugh, H. Lee, D. ]. Anderson, A. I. Basbaum, Pain 151, 422-429 (2010). 27. W. A. Catterall, Physiol. Rev. 72 (suppl.), S15-S48 (1992). 28. W. A. Catterall, Neuron 26, 13-25 (2000). 29. W. A. Catterall, A. L. Goldin, S. G. Waxman, International Union of Pharmacology, Pharmacol. Rev. 57, 397-409 (2005). 30. ]. C. Rogers, Y. Qu, T. N. Tanada, T. Scheuer, W. A. Catterall,Biol. Chem. 271, 15950-15962 (1996). 31. S. Cestele et ai, Neuron 21, 919-931 (1998). 32. R. C. Rodriguez de la Vega, L. D. Possani, Toxicon 46, 831-844 (2005). 33. ]. Z. Zhang etal.J. Biol. Chem. 287, 30719-30728 (2012). 34. M. Gurevitz, Toxicon 60, 502-511 (2012). 35. H. ]. Kreienkamp, S. M. Sine, R. K. Maeda, P. Taylor, }. Biol. Chem. 269, 8108-8114 (1994). 36. Z. Takacs, K. C. Wilhelmsen, S. Sorota, Mol. Biol. Evol. 18, 1800-1809 (2001). 37. Y. Kaneko, G. Matsumoto, Y. Hanyu, Biochem. Biophys. Res. Commun. 240, 651-656 (1997). 38. M. Yotsu-Yamashita et ai, Biochem. Biophys. Res. Commun. 267, 403-412 (2000). 39. S. Geffeney, E. D. Brodie Jr., P. C. Ruben, E. D. Brodie 3rd, Science 297, 1336-1339 (2002). 40. B. Venkatesh et ai, Curr. Biol. 15, 2069-2072 (2005). 41. T. ]. Park et ai, PLOS Biol. 6, el3 (2008). 42. E. S. Smith et ai, Science 334, 1557-1560 (2011). 43. ]. Gilchrist, F. Bosmans, Toxins 4, 620-632 (2012). Acknowledgments: We thank M. Heitlinger, the Santa Rita Experimental Range (Univ. of Arizona), and the Arizona Game and Fish Department for assistance with animal collections. We also thank Y. Lu and M. Wu for technical assistance with Navl.8 sequencing and construct assembly. This work was supported, in part or in whole, by NSF I0S Award 1122115 (to A.H.R., M.P.R., and H.H.Z.), Department of the Army grants W911NF-06-1-0213 and W911NF-09-1-0355 from the Army Research Office Life Sciences Division (to A.H.R. and H.H.Z.), NIH grant NS 053422 from the National Institute of Neurological Disorders and Stroke (to T.R.C. and Y.X.), and a Faculty Research Grant from the Office of Research and Sponsored Projects, Sam Houston State University (to M.P.R.). The Department of Biological Sciences at Sam Houston State University provided logistical support for fieldwork. We declare no conflict of interest. The data are included in the main article and in the supplementary materials. The gene (ScnlOa) encoding 0. torridus Navl.8 has been deposited in NCBI's GenBank gene database. Information about the GenBank accession numbers can be found in the supplementary materials. Supplementary Materials www.sciencemag.org/content/342/6157/441/suppl/DCl Materials and Methods Figs. SI to S6 Movie SI 12 February 2013; accepted 27 September 2013 10.1126/science.l236451 446 25 OCTOBER 2013 VOL 342 SCIENCE www.sciencemag.org